根據 nettime-l 的引述，倫敦金融時報（The Financial Times Limited 2007）的報導，印尼原本想要掌握禽流感的專利，扣住基因序列資訊，然後 2/17 又決定釋放。nettime-l 的編輯之一的 Ted 這麼說的：
Initial reports were that Indonesia planned withhold samples of the H5N1 bird flu it had isolated in order to ‘keep control of intellectual property rights’ in an exclusive deal with Baxter. It then transpires that the govt had concluded that the normal approach to ‘sharing’ sample with the WHO led to the WHO ‘sharing’ samples with pharmacorps, which would then screw high prices for derivative vaccines out of the country that ‘shared’ originary samples. Once that came out, the govt agreed — after a notably short five-hour negotiation — to ‘share’ them, ‘but only after steps were taken to ensure developing countries get fair and equitable access to vaccines.’ Which makes it sound, in a classic mode of journalistic ~misrepresentation, as though the WHO caved in very quickly when its role in facilitating expropriation of knowledge that is at once indigenous *and* ‘high-tech’ was exposed.
This might be a very interesting precursor of a trend in which LDCs with access to critical ~primary sources play an extreme-sounding IPR card, not so much to profit from it but, rather, to demolish normal cycles of loss after loss. It’s hard to tell from the thin coverage; but it’s interesting to specualte about other applications of this approach to disassembling rentier networks.